AI assistant
Sending…
RESMED INC — Director's Dealing 2012
Aug 8, 2012
30071_dirs_2012-08-08_f8a3c831-fa1a-4f07-8a5c-e590c14e4720.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2012-08-06
Reporting Person: WAREHAM JOHN P (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-08-06 | ResMed Common Stock | M | 12000 | $23.095 | Acquired | 22000 | Direct |
| 2012-08-06 | ResMed Common Stock | S | 12000 | $35.7354 | Disposed | 10000 | Direct |
| 2012-08-07 | ResMed Common Stock | M | 5942 | $21.025 | Acquired | 15942 | Direct |
| 2012-08-07 | ResMed Common Stock | S | 5942 | $35.80 | Disposed | 10000 | Direct |
| 2012-08-07 | ResMed Common Stock | M | 9058 | $21.025 | Acquired | 19058 | Direct |
| 2012-08-07 | ResMed Common Stock | S | 9058 | $36.12 | Disposed | 10000 | Direct |
| 2012-08-07 | ResMed Common Stock | M | 3000 | $21.025 | Acquired | 13000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-08-06 | ResMed NQ Stock Options | $23.095 | M | 12000 | Disposed | 2013-11-10 | ResMed Common Stock (12000) | Direct |
| 2012-08-07 | ResMed NQ Stock Options | $21.025 | M | 5942 | Disposed | 2014-11-07 | ResMed Common Stock (5942) | Direct |
| 2012-08-07 | ResMed NQ Stock Options | $21.025 | M | 9058 | Disposed | 2014-11-07 | ResMed Common Stock (9058) | Direct |
| 2012-08-07 | ResMed NQ Stock Options | $21.025 | M | 3000 | Disposed | 2014-11-07 | ResMed Common Stock (3000) | Direct |
Footnotes
F1: Represents date options first became exercisable.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29